Concepedia

Marcos R. Estecio

MR

Statistics

Publications

65

Citations

6.8K

H-Index

43

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Temple University

The University of Texas Health Science Center at Houston

Genesis Foundation

Baylor College of Medicine

Marcos R. Estecio is an author at The University of Texas MD Anderson Cancer Center specializing in epigenetics, cancer epigenetics, and oncology.

ORCID

Publications per year

2002–2024

65

Publications

65

Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

Hui Yang, Carlos E. Bueso‐Ramos, Courtney DiNardo et al. · Leukemia · 2013 · 684 citations · Full text

, , +10

<i>CCAT2</i>, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

Hui Ling, Riccardo Spizzo, Yaser Atlasi et al. · Genome Research · 2013 · 611 citations · Full text

, , +17

<i>Fusobacterium</i> in Colonic Flora and Molecular Features of Colorectal Carcinoma

Tomomitsu Tahara, Eiichiro Yamamoto, Hiromu Suzuki et al. · Cancer Research · 2014 · 472 citations · Full text

, , +17

DNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia

Allen S. Yang, Ketan D. Doshi, Sang‐Woon Choi et al. · Cancer Research · 2006 · 268 citations

, , +15

Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response

Kevin C. Johnson, Kevin Anderson, Elise T. Courtois et al. · Nature Genetics · 2021 · 267 citations · Full text

, , +17

1–5 of 65